View the content of this email online

Successful gene Knock-In with CRISPR/Cas9 mediated by LentiFlash® delivery

KI with LentiFlash V5
The combination of LentiFlash® particles carrying CRISPR/Cas9 and IDLV allows the addition of mCherry DNA into the GFP gene in any target cell without damages
Separator

Highly purified and concentrated LentiFlash® particles combined with an IDLV show:

 

Efficient Knock-In results on human primary T cells (as shown on our poster)

 

 The preservation of the original cell phenotype, proliferation and viability

These promising results make LentiFlash® a game changing technology for the development of innovative strategy from discovery to clinical applications

TO TAKE A LOOK AT THE POSTER

Click Here

Follow us

Twitter Flash Therapeutics LinkedIn Flash Therapeutics Youtube Flash Therapeutics Google + Flash Therapeutics
www.flashtherapeutics.com
© Flash Therapeutics 2018

Click here to unsuscribe from the mailing list